We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRG
1251
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$220K 0.01%
+17,330
New +$233K
CBM
1252
DELISTED
Cambrex Corporation
CBM
$220K 0.01%
+5,001
New +$207K
PTH icon
1253
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$219M
$219K 0.01%
10,338
BOKF icon
1254
BOK Financial
BOKF
$8.6B
$218K 0.01%
+3,130
New +$205K
BEAV
1255
DELISTED
B/E Aerospace Inc
BEAV
$218K 0.01%
3,973
+24
+0.6% +$1.43K
GDO
1256
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.2M
$217K 0.01%
12,652
+1,900
+18% +$33.8K
BYM
1257
DELISTED
BlackRock Municipal Income Quality Trust
BYM
$216K 0.01%
15,900
+1,600
+11% +$22.4K
RWJ icon
1258
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.04B
$216K 0.01%
11,163
INSY
1259
DELISTED
Insys Therapeutics, Inc.
INSY
$216K 0.01%
+6,001
New +$187K
ATAXZ
1260
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$216K 0.01%
39,000
-4,000
-9% -$22.2K
ALSN icon
1261
Allison Transmission
ALSN
$9.59B
$215K 0.01%
+7,342
New +$228K
VMO icon
1262
Invesco Municipal Opportunity Trust
VMO
$654M
$215K 0.01%
17,600
-2,002
-10% -$25.3K
BGH
1263
Barings Global Short Duration High Yield Fund
BGH
$281M
$214K 0.01%
10,719
-2,200
-17% -$45.2K
RWK icon
1264
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.31B
$214K 0.01%
4,322
SGEN
1265
DELISTED
Seagen Inc. Common Stock
SGEN
$214K 0.01%
+4,426
New +$183K
SODA
1266
DELISTED
SodaStream International Ltd
SODA
$213K 0.01%
+10,040
New +$212K
KYE
1267
DELISTED
Kayne Anderson Energy
KYE
$213K 0.01%
+10,060
New +$241K
IXP icon
1268
iShares Global Comm Services ETF
IXP
$524M
$212K 0.01%
3,404
-529
-13% -$33.7K
SSYS icon
1269
Stratasys
SSYS
$687M
$212K 0.01%
6,068
-565
-9% -$23.7K
EXG icon
1270
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.98B
$211K 0.01%
21,748
-2,077
-9% -$20.6K
IPG
1271
DELISTED
Interpublic Group of Companies
IPG
$211K 0.01%
10,946
-53
-0.5% -$1.1K
PETX
1272
DELISTED
Aratana Therapeutics, Inc.
PETX
$211K 0.01%
+14,000
New +$202K
EPIQ
1273
DELISTED
EPIQ SYSTEMS INC
EPIQ
$211K 0.01%
12,500
ANSS
1274
DELISTED
Ansys
ANSS
$210K 0.01%
2,307
-971
-30% -$86.3K
VRP icon
1275
Invesco Variable Rate Preferred ETF
VRP
$2.98B
$210K 0.01%
8,500

Similar funds

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.